ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1689

Pulmonary Function Test Reference Equations May Drive Inequitable Classification of Restrictive Lung Disease Severity in Systemic Sclerosis

Kamini Kuchinad1, Rachel Wallwork2, Matthew Lammi3, Christopher Mecoli1, Julie Paik1, Fredrick Wigley4, Robert Wise1, Laura Hummers5, Ami Shah6 and Ji Soo Kim1, 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University, Towson, MD, 3Johns Hopkins University Division of Pulmonary and Critical Care Medicine, Baltimore, MD, 4Johns Hopkins University, Division of Rheumatology, Baltimore, MD, Baltimore, MD, 5Johns Hopkins University, Division of Rheumatology, Baltimore, MD, Ellicott City, MD, 6Division of Rheumatology, Johns Hopkins University, Ellicott City, MD

Meeting: ACR Convergence 2024

Keywords: Health Services Research, interstitial lung disease, Measurement Instrument, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: Systemic Sclerosis & Related Disorders – Clinical I

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Black individuals with systemic sclerosis (SSc) have an increased frequency and severity of interstitial lung disease (ILD) as compared to their White counterparts. Pulmonary function tests (PFTs) are critical in the diagnosis and monitoring of ILD among individuals with SSc. PFT reference equations (e.g., National Health and Nutrition Examination Survey [NHANES], Global Lung Initiative 2012 [GLI 2012]) previously used race as a variable for calculating the percent predicted forced vital capacity (ppFVC), a practice without biologic basis  Race-neutral equations (referred to as GLI Global) have recently been developed. In this study, we sought to examine how the use of race-specific and race-neutral equations affects the classification of lung function in Black and White patients with SSc.

Methods: Using data from a large, single-center, North American systemic sclerosis cohort, baseline percent predicted FVC (ppFVC) values were calculated for self-identified Black and White patients using race specific (NHANES, GLI 2012) and race neutral (GLI Global) equations. Lung function was classified as normal (≥80% ppFVC) or mild (70-79% ppFVC), moderate (60-69% ppFVC), severe (50-59% ppFVC) or very severe (< 50% ppFVC) restrictive lung disease (RLD). The percentage of Black and White individuals who switched RLD severity classification categories with the use of the race neutral as compared to race specific equations was calculated.

Results: 2909 White patients and 641 Black patients were included in this study. Black individuals had lower baseline FVC (2.4 L vs 3.0 L, p< 0.0001) and diffusing capacity of the lungs for carbon monoxide (12.8 mL/min/mmHg vs 16.0 mL/min/mmHg, p< 0.0001) than White individuals. Figure 1 demonstrates the effect of race-specific and race-neutral equations on calculation of ppFVC across age groups for males and females. For each age group, we observe that race-specific equations systematically overestimate RLD severity for White individuals and underestimate RLD severity for Black individuals. When comparing the race-specific GLI 2012 equations to the race-neutral GLI Global equations, 45% of Black individuals were reclassified as having more severe RLD with the use of race-neutral reference equations (Figure 2). Conversely, 16% of White individuals were reclassified to a less severe RLD category with the use of race-neutral vs race-specific equations.

Conclusion: Changing reference equations can significantly affect the classification of RLD among Black and White individuals with SSc. The use of race-specific reference equations in PFTs may result in systematic underdiagnosis and misclassification of ILD severity among Black individuals with SSc. Importantly, these findings suggest that the use of race-specific PFT reference equations could impede appropriate health care delivery in Black patients with SSc, including initiation of immunosuppression, clinical trial eligibility and referral for lung transplantation.

Supporting image 1

Figure 1: The effect of race-specific and race-neutral equations on calculation of percent predicted FVC (ppFVC) across age groups in female and male SSc patients

Supporting image 2

Figure 2: The effect of race neutral reference equations on classification of restrictive lung disease (RLD) severity


Disclosures: K. Kuchinad: None; R. Wallwork: None; M. Lammi: None; C. Mecoli: Argenx, 1, Department of Justice, 2; J. Paik: ArgenX, 2, 5, AstraZeneca, 5, Guidepoint Consulting, 2, Pfizer, 2, Priovant, 5; F. Wigley: None; R. Wise: None; L. Hummers: AbbVie/Abbott, 2, AstraZeneca, 5, Biotest, 1, 2, Boehringer-Ingelheim, 2, 5, Cumberland, 5, GlaxoSmithKlein(GSK), 5, Kadmon, 5, Medpace, 5, Merck/MSD, 5, Mitsubishi Tanabe, 5, prometheus, 5; A. Shah: Arena Pharmaceuticals, 5, Kadmon, 5, Medpace LLC, 5; J. Kim: None.

To cite this abstract in AMA style:

Kuchinad K, Wallwork R, Lammi M, Mecoli C, Paik J, Wigley F, Wise R, Hummers L, Shah A, Kim J. Pulmonary Function Test Reference Equations May Drive Inequitable Classification of Restrictive Lung Disease Severity in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/pulmonary-function-test-reference-equations-may-drive-inequitable-classification-of-restrictive-lung-disease-severity-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pulmonary-function-test-reference-equations-may-drive-inequitable-classification-of-restrictive-lung-disease-severity-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology